High-Dose Glucocorticoids for the Treatment of Sudden Hearing Loss.
Journal
NEJM evidence
ISSN: 2766-5526
Titre abrégé: NEJM Evid
Pays: United States
ID NLM: 9918317485806676
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
medline:
7
2
2024
pubmed:
7
2
2024
entrez:
6
2
2024
Statut:
ppublish
Résumé
High-Dose Glucocorticoids for Sudden Hearing LossThis trial compared courses of high-dose intravenous prednisolone or high-dose oral dexamethasone versus standard-dose oral prednisone in adults with idiopathic sudden sensorineural hearing loss. At 30 days, systemic high-dose glucocorticoid therapy was not superior to a lower-dose regimen with respect to change in hearing threshold, and it was associated with a higher risk of side effects.
Identifiants
pubmed: 38320514
doi: 10.1056/EVIDoa2300172
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM